abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG Tablet for Oral Suspension
RxNorm concept 2598348, clinical drug (scd). Prescribable name: abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension.
- RxCUI
- 2598348
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2598348 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
abacavir 60 MG (as abacavir sulfate 70.2 MG) / dolutegravir 5 MG (as dolutegravir sodium 5.26 MG) / lamiVUDine 30 MG Tablet for Oral Suspension; abacavir 60 MG (as abacavir sulfate 70.2 MG) / dolutegravir 5 MG (as dolutegravir sodium 5.26 MG) / lamivudine 30 MG Tablet for Oral Suspension; abacavir 60 MG / dolutegravir 5 MG / 3TC 30 MG Tablet for Oral Suspension; abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension
Related concepts
- lamivudine 30 MG (SCDC, consists of)
- dolutegravir 5 MG (SCDC, consists of)
- abacavir 60 MG (SCDC, consists of)
- Tablet for Oral Suspension (DF, has dose form)
- abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG Tablet for Oral Suspension [Triumeq] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2598348 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2598348 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2598348. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.